Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pa...
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
About this item
Full title
Author / Creator
Steingart, Richard M., MD , Bakris, George L., MD , Chen, Helen X., MD , Chen, Ming-Hui, MD, MMSc , Force, Thomas, MD , Ivy, S. Percy, MD , Leier, Carl V., MD , Liu, Glenn, MD , Lenihan, Daniel, MD , Lindenfeld, JoAnn, MD , Maitland, Michael L., MD, PhD , Remick, Scot C., MD and Tang, W.H. Wilson, MD
Publisher
New York, NY: Mosby, Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Mosby, Inc
Subjects
More information
Scope and Contents
Contents
Background Interfering with angiogenesis is an effective, widely used approach to cancer therapy, but antiangiogenic therapies have been associated with important systemic cardiovascular toxicities such as hypertension, left ventricular dysfunction, heart failure, and myocardial ischemia and infarction. As the use of vascular endothelial growth fac...
Alternative Titles
Full title
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_920230599
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_920230599
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2011.10.018
